Concepedia

Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report

Timothy Kwang Yong Tay, Joe Yeong, Eileen Xueqin Chen, Xin Xiu Sam, Johnathan Xiande Lim, Jason Yongsheng Chan

JCO Precision Oncology · 2022 · 14 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

FIG 5. Multiplex immunohistochemistry/immunofluorescence applied to a section of the tumor showed various tumor-infiltrating immune cells: (A) CD3, (B) CD8, (C) CD68, (D) FOXP3, and (E) PD-L1. PD-L1-positive cells (19.7%) were also present. PD-L1, programmed death ligand-1.

References

29

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text

, , +17

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le, Jennifer N. Durham, Kellie N. Smith et al. · Science · 2017 · 6.6K citations

, , +17

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto et al. · Journal of Clinical Oncology · 2019 · 3K citations · Full text

, , +17

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Aurélien Marabelle, Marwan Fakih, Juanita Lopez et al. · The Lancet Oncology · 2020 · 2.5K citations · Full text

, , +17

Landscape of Microsatellite Instability Across 39 Cancer Types

Russell Bonneville, Melanie A. Krook, Esko A. Kautto et al. · JCO Precision Oncology · 2017 · 1.5K citations

, , +17